Details

Biologic drugs (Schedule D drugs) – Division 4 proposed regulatory amendments: Notice to stakeholders - Canada.ca

Metadata and links for an archived snapshot.

Source: Health Canada
Date: Jan 26, 2026 · edition #6
Timestamp: 2026-01-26T11:28:12.573Z
Language: en
Original URL: https://www.canada.ca/en/health-canada/programs/consultation-proposed-agile-regulations-guidance-licensing-drugs-medical-devices/biologic-drugs-schedule-d-division-4-proposed-regulatory-amendments-notice.html
Replay URL: https://replay.healtharchive.ca/job-6/20260126112812/https://www.canada.ca/en/health-canada/programs/consultation-proposed-agile-regulations-guidance-licensing-drugs-medical-devices/biologic-drugs-schedule-d-division-4-proposed-regulatory-amendments-notice.html#ha_snapshot=415496
ID: 415496
Status: 200
Type: text/html

Independent archive · Not an official government website. For up-to-date recommendations, always consult the official source website.

Other snapshots